Evolution of Nerve Conduction Demyelinating Parameters Between Baseline and Treatment Cessation May Not Be Predictive of Relapse in IVIg-Responsive CIDP Patients.

Key Points

• The research aims to determine the predictive ability of follow-up nerve conduction studies for relapse in CIDP patients receiving IVIg treatment.
• Analyzed nerve conduction studies in IVIg-responsive CIDP patients
• Monitored changes in demyelination parameters between baseline and treatment cessation
• Evaluated the relationship between these studies and relapse rates
• No predictive value of follow-up nerve conduction studies on relapse was demonstrated
• Indicated a need to explore additional biomarkers for better prediction